Journal of Endocrinological Investigation

, Volume 4, Issue 1, pp 21–29 | Cite as

Androblastoma: Pre-, per- and post-operative steroid hormone and binding protein concentrations in peripheral plasma, cyst fluid and tumor vein

  • P. H. Rolland
  • P. M. Martin
  • A. M. Rolland
  • F. Laffargue
  • H. Serment


A case-report of arrhenoblastoma is presented where the endocrine profile has been determined before, during and after removal of the tumor. Sex steroids, cortisol, corticosteroid binding globulin (CBG) and sex steroid binding protein (SBP) were measured in fluid from 2 cysts, tumor vein and peripheral plasma. Hormones were measured by specific RIAs after stepwise chromatography on celite support according to a new elution pattern allowing the resolution of 8 sex steroids in a single chromatographic system. Excessive amounts of androgen, the most prominent being testosterone, and 17-OH-progesterone, but low levels of estrogens and progesterone were found in preoperative plasma. Due to an androgen-directed rise of CBG, large amounts of plasma cortisol were detected. However, preoperative SBP capacity was found to be reduced. The steroid profile of cyst fluids was found to be similar to that of peripheral plasma. Neoplastic cells were found capable of producing an androgen binding protein. These results correlated well with Sertoli-Leydig cell tumors histology, i.e. a testis-like endocrine structure. From the endocrine profile, the steroid biosynthetic pathways are discussed with respect to the possibility that biosynthesis, once the 17-OH-pregnenolone structure was reached, was active along both the δ 5 and δ 4-steroid pathways. The steroid levels in tumor vein and their corres-ponding gradients to the periphery are discussed with respect to: i) the possibility of metabolic and biosynthetic capacities of cancer cells bearing an undifferentiated steroidogenic appearance, ii) the possibility for tumor steroid secretion by others means than by venous blood and iii) the possibility that both point i) and ii) could be the cause of inconsistent diagnosis significant of endocrine profile as observed in some patients.


Androblastoma sex steroids 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cantor B., Pierson K.K., Kalpa P.A. Hormones studies in a gynandroblastoma. Fertil. Steril. 29: 681, 1978.PubMedGoogle Scholar
  2. 2.
    Greenblatt R.B., Mahesh V.B, Campbell R.D. Arrhenoblastoma: three cases report. Obstet. Gynecol. 39: 567, 1978.Google Scholar
  3. 3.
    Kase N., Conrad S.H. Steroid synthesis in abnormal ovaries. Am. J. Obstet. Gynecol. 90: 1251, 1964.PubMedGoogle Scholar
  4. 4.
    Laatikainen T., Pelkonen R., Vihko R. Plasma steroids in two subjects with ovarian androgen producing tumors, arrhenoblastoma and gynandroblastoma. J. Clin. Endocrinol. Metab. 35: 535, 1972.CrossRefGoogle Scholar
  5. 5.
    Maidman J.E., Chattertton R.T., Arrata W.S.M., Shikano J., Lueck J. Steroid metabolism in arrhenoblastoma. Obstet. Gynecol. 44: 333, 1974.PubMedGoogle Scholar
  6. 6.
    Mahesh V.V., McDonough P.G., Deleo C.A. Endocrine studies in the arrhenoblastoma. Am. J. Obstet. Gynecol. 107: 183, 1970.PubMedGoogle Scholar
  7. 7.
    Sato T., Shiwada T., Matsumoto S. A clinical and metabolic study of masculinizing arrheno-b lastoma. Am. J. Obstet. Gynecol. 107: 1124, 1969.Google Scholar
  8. 8.
    Savard K., Gut M., Dorfman R.I., Gabrilove J.L., Soffer L.J. Formation of androgens by human arrhenoblastoma tissue in vitro. J. Clin. Endocrinol. Metab. 21: 165, 1971.CrossRefGoogle Scholar
  9. 9.
    Serment H., Piana L., Erny R., Laffargue F. Les tumeurs endocrines de l’ovaire. Encycl. Med. Chir. Gynecol. (Paris) 11: 680, 1973.Google Scholar
  10. 10.
    Serment H., Laffargue F., Bouhaben M.C., Martin P.M. Biologie des tumeurs de l’ovaire. In: Masson (Eds.), Tumeurs de l’ovaire Paris, 1973, p. 121.Google Scholar
  11. 11.
    Serment H., Piana L. Tumeurs endocrines de l’ovaire. Expansion Scientifique Française, Paris, 1964.Google Scholar
  12. 12.
    Soules M.R., Abraham G.E., Bossen E.H. The steroid profile of a virilizing ovarian tumor. Obstet. Gynecol. 52: 73, 1978.PubMedGoogle Scholar
  13. 13.
    Younglay E.V., Richman H., Atyeo R., Johnson F.L. Arrhenoblastoma in vivo and in vitro studies. Am. J. Obstet. Gynecol. 116: 401, 1973.Google Scholar
  14. 14.
    Forest M.G., Orgiazzi J., Tranchant D., Mornex R., Bertrand J. Approach to the mechanism of androgen overproduction in a case of Krukenberg tumor responsible for virilization during pregancy. J. Clin. Endocrinol. Metab. 47: 428, 1978.PubMedCrossRefGoogle Scholar
  15. 15.
    Meldrum D.R., Abraham G.E. Peripheral and ovarian venous concentrations of various steroid hromones in virilizing ovarian tumors. Obstet. Gynecol. 53: 36, 1979.PubMedGoogle Scholar
  16. 16.
    Muechler E.K., Grove S., Kholer D. Steroid hormones in ovarian vein and cyst fluid of a virilizing stromal tumor. Obstet. Gynecol. 52: 609, 1978.PubMedGoogle Scholar
  17. 17.
    Kurman R.J., Andrade D., Goebbelsmann U., Taylor C.R. An immunohistologic study of steroid localization in Sertoli-Leydig tumors of the ovary and testis. Cancer 42: 1772, 1978.PubMedCrossRefGoogle Scholar
  18. 18.
    Serow S.F., Escully R., Sobin L.H. International histological classification of tumor. No. 13, Histological typing of ovarian tumors. World Health Organization, Geneva, 1973.Google Scholar
  19. 19.
    Deperetti E., Forest M.G. Unconjugated DHEA plasma levels in normal subjects from birth to adolescence in human: The use of a sensitive radioimmunoassay. J. Clin. Endocrinol. Metab. 43: 892, 1976.Google Scholar
  20. 20.
    Forest M.G., Cathiard A.M., Bertrand J. Total and unbound testosterone levels in newborn and normal and hypogonadal children: use of a sensitive radioimmunoassay for testosterone. J. Clin. Endocrinol. Metab. 36: 1132, 1974.CrossRefGoogle Scholar
  21. 21.
    Forest M.G. Use of highly specific antibodies against 17-OH-Progesterone in a simplified radioimmunoassay and in the simultaneous determination of 4 sex hormones in plasma. Horm. Res. 7: 260, 1976.PubMedCrossRefGoogle Scholar
  22. 22.
    Martin P.M., Rolland P.H., Jacquemier, Rolland A.M., Toga M. Multiple steroid receptor in human breast cancer β-I-Technological features. Biomedicine 28: 278, 1978.PubMedGoogle Scholar
  23. 23.
    Fhamy D., Read G.F., Hillier S.G. Some observations on the determination of cortisol in human plasma by radioimmunoassay using antisera against cortisol-3-BSA. Steroids 26: 267, 1975.CrossRefGoogle Scholar
  24. 24.
    Radman M.H., Bhagavan B.S., Strummer D. Arrhenoblastoma of the ovary. Am. J. Obstet. Gynecol. 106: 1187, 1970.PubMedGoogle Scholar
  25. 25.
    Yanaihara T., Troen P. Biosynthetic pathways for androgen formation in human testicular tissue in vitro. J. Clin. Endocrinol. Metab. 34: 783, 1972.PubMedCrossRefGoogle Scholar
  26. 26.
    Ances L.G., Ganis F.M. Metabolism of testosterone by virilizing Krukenberg tumor of the ovary. Am. J. Obstet. Gynecol. 100: 1062, 1968.PubMedGoogle Scholar
  27. 27.
    Vigersky R.A., Loriaux D. An androgen binding protein in the cytosol of patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 43: 817, 1976.PubMedCrossRefGoogle Scholar
  28. 28.
    Ritzen E.M., Dobbins M.C., Tindall D.J., French F.S., Nayfeh S.N. Characterization of an androgen binding protein (ABP) in rat testis and epididymis. Steroids 22: 593, 1973.CrossRefGoogle Scholar
  29. 29.
    Hansson V., Ritzen E.M., French R.S., Nayfeh S.N. Androgen transport and receptor mechanisms in testis and epididymis. In: Greer M.A., Salmon D.H. (Eds.), Handbook of physiology. American Physiology Society, Washington DC, 1975, p. 173.Google Scholar
  30. 30.
    Rodriguez-Rigau L.J., Weiss D.B., Smith K.D., Steinberger E. Suggestion of abnormal testicular steroidogenesis in some oligospermic men. Acta Endocrinol. 87: 400, 1978.PubMedGoogle Scholar
  31. 31.
    Ishida T., Okagaki T., Tagatz G.E., Jacobson M.E., Doe R.P. Lipid cell tumor of the ovary. An ultrastructural study. Cancer 40: 234, 1977.PubMedCrossRefGoogle Scholar
  32. 32.
    Rice B.F., Savard K. Steroid formation in the human ovary-IV-Ovarian stromal formation of radioactive steroids from acetate-1-14C and action of gonadotrophins. J. Clin. Endocrinol. Metab. 26: 593:1966.PubMedCrossRefGoogle Scholar
  33. 33.
    Laffargue P. Tumeurs a cellules lipidiques. In: Masson (Eds.), Tumeurs de l’ovaire. Paris. 1975, p. 121.Google Scholar
  34. 34.
    Bonaventura L.M., Judd H., Roth L.M., Clearly R.E. Androgen, estrogen and progestogen production by a lipid cell tumor of the ovary. Am. J. Obstet. Gynecol. 131: 403, 1978.PubMedGoogle Scholar
  35. 35.
    George F.W., Wilson J.D. Conversion of androgen to estrogen by the human fetal ovary. J. Clin. Endocrinol. Metab. 47: 550, 1978.PubMedCrossRefGoogle Scholar
  36. 36.
    Hughesdon P.E. Ovarian lipoid and thecal cell tumor. Their origin and interrelations. Obstet. Gynecol. Surv. 21: 245, 1966.PubMedCrossRefGoogle Scholar
  37. 37.
    Koss L.G., Rothschild E.O., Fleischer M., Francis J.E. Masculinizing tumor of the ovary apparently with adre-nocortical activity. Cancer 23: 1245, 1969.PubMedCrossRefGoogle Scholar
  38. 38.
    Lipsett M.B., Kirshner M.A., Wilson H., Bardin C.W. Malignant lipoid cell tumor of the ovary: clinical, biochemical and etiological consideration. J. Clin. Endocrinol. Metab. 30: 336, 1970.PubMedCrossRefGoogle Scholar
  39. 39.
    Pedowitz P., Pomerance W. Adrenal-like tumors of the ovary. Review of the literature and report of 2 new cases. Obstet. Gynecol. 16: 62, 1962.Google Scholar
  40. 40.
    Ireland K., Woodruff J.D. Masculinizing ovarian tumors. Obstet. Gynecol. Surv. 31: 83, 1976.PubMedCrossRefGoogle Scholar
  41. 41.
    Novak E.R. Pathology of ovarian tumors. In: Lewis G.C., (Eds.), New Concept in Gynecological Oncology. F.A. Davis, Co-Philadelphia, 1968, p. 311.Google Scholar
  42. 42.
    Diammond M., Rust N., Westphal U. High affinity binding to progesterone, testosterone and cortisol in normal and androgen treated Guinea pig during various reproductive stages: relationship to mascu-linization. Endocrinology 84: 1143, 1969.CrossRefGoogle Scholar
  43. 43.
    Heyns W., Demoor P. Kinetics of 17-hydroxysteroids from the steroid binding globulin of human plasma. J. Clin. Endocrinol. Metab. 32: 147, 1971.PubMedCrossRefGoogle Scholar
  44. 44.
    Sandberg A.A., Slaunwhite W.R. Transcortin: a corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens. J. Clin. Invest. 38: 1290, 1959.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Wenn R.V., Kamberi I.A., Vossough P., Karimnejad M.H., Torabee Ayoughi F.I., Keyvanjah M., Sarbert N. Human testosterone-estradiol binding globulin in health and diseases. Acta Endocrinol. (Kbh.), 84: 850, 1977.Google Scholar
  46. 46.
    Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265, 1951.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1981

Authors and Affiliations

  • P. H. Rolland
    • 1
    • 2
  • P. M. Martin
    • 1
    • 2
  • A. M. Rolland
    • 1
    • 2
  • F. Laffargue
    • 1
    • 2
  • H. Serment
    • 1
    • 2
  1. 1.Laboratoire de Cancérologie ExpérimentaleFaculté Nord de MédecineMarseille Cedex 3France
  2. 2.Clinique Obstétricale et GynécologiqueHôpital de la ConceptionMarseille Cedex 4France

Personalised recommendations